434 related articles for article (PubMed ID: 25587796)
1. Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells.
Aliper AM; Csoka AB; Buzdin A; Jetka T; Roumiantsev S; Moskalev A; Zhavoronkov A
Aging (Albany NY); 2015 Jan; 7(1):26-37. PubMed ID: 25587796
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
[TBL] [Abstract][Full Text] [Related]
3. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
Brassard JA; Fekete N; Garnier A; Hoesli CA
Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
[TBL] [Abstract][Full Text] [Related]
4. Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome.
Halaschek-Wiener J; Brooks-Wilson A
J Gerontol A Biol Sci Med Sci; 2007 Jan; 62(1):3-8. PubMed ID: 17301031
[TBL] [Abstract][Full Text] [Related]
5. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis.
Bridger JM; Kill IR
Exp Gerontol; 2004 May; 39(5):717-24. PubMed ID: 15130666
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.
Chen Z; Chang WY; Etheridge A; Strickfaden H; Jin Z; Palidwor G; Cho JH; Wang K; Kwon SY; Doré C; Raymond A; Hotta A; Ellis J; Kandel RA; Dilworth FJ; Perkins TJ; Hendzel MJ; Galas DJ; Stanford WL
Aging Cell; 2017 Aug; 16(4):870-887. PubMed ID: 28597562
[TBL] [Abstract][Full Text] [Related]
7. p53 isoforms regulate premature aging in human cells.
von Muhlinen N; Horikawa I; Alam F; Isogaya K; Lissa D; Vojtesek B; Lane DP; Harris CC
Oncogene; 2018 May; 37(18):2379-2393. PubMed ID: 29429991
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
9. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
McClintock D; Gordon LB; Djabali K
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
[TBL] [Abstract][Full Text] [Related]
10. Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging.
Chang W; Wang Y; Luxton GWG; Östlund C; Worman HJ; Gundersen GG
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3578-3583. PubMed ID: 30808750
[TBL] [Abstract][Full Text] [Related]
11. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.
Scaffidi P; Misteli T
Nat Med; 2005 Apr; 11(4):440-5. PubMed ID: 15750600
[TBL] [Abstract][Full Text] [Related]
12. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis.
Csoka AB; English SB; Simkevich CP; Ginzinger DG; Butte AJ; Schatten GP; Rothman FG; Sedivy JM
Aging Cell; 2004 Aug; 3(4):235-43. PubMed ID: 15268757
[TBL] [Abstract][Full Text] [Related]
13. Longwave UV light induces the aging-associated progerin.
Takeuchi H; Rünger TM
J Invest Dermatol; 2013 Jul; 133(7):1857-62. PubMed ID: 23392295
[TBL] [Abstract][Full Text] [Related]
14. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic deregulation of lamina-associated domains in Hutchinson-Gilford progeria syndrome.
Köhler F; Bormann F; Raddatz G; Gutekunst J; Corless S; Musch T; Lonsdorf AS; Erhardt S; Lyko F; Rodríguez-Paredes M
Genome Med; 2020 May; 12(1):46. PubMed ID: 32450911
[TBL] [Abstract][Full Text] [Related]
16. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment.
Columbaro M; Capanni C; Mattioli E; Novelli G; Parnaik VK; Squarzoni S; Maraldi NM; Lattanzi G
Cell Mol Life Sci; 2005 Nov; 62(22):2669-78. PubMed ID: 16261260
[TBL] [Abstract][Full Text] [Related]
17. Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity.
García-Aguirre I; Alamillo-Iniesta A; Rodríguez-Pérez R; Vélez-Aguilera G; Amaro-Encarnación E; Jiménez-Gutiérrez E; Vásquez-Limeta A; Samuel Laredo-Cisneros M; Morales-Lázaro SL; Tiburcio-Félix R; Ortega A; Magaña JJ; Winder SJ; Cisneros B
Aging Cell; 2019 Oct; 18(5):e13002. PubMed ID: 31305018
[TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
[TBL] [Abstract][Full Text] [Related]
19. The Molecular and Cellular Basis of Hutchinson-Gilford Progeria Syndrome and Potential Treatments.
Batista NJ; Desai SG; Perez AM; Finkelstein A; Radigan R; Singh M; Landman A; Drittel B; Abramov D; Ahsan M; Cornwell S; Zhang D
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980874
[TBL] [Abstract][Full Text] [Related]
20. Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome.
Díez-Díez M; Amorós-Pérez M; de la Barrera J; Vázquez E; Quintas A; Pascual-Figal DA; Dopazo A; Sánchez-Cabo F; Kleinman ME; Gordon LB; Fuster V; Andrés V; Fuster JJ
Geroscience; 2023 Apr; 45(2):1231-1236. PubMed ID: 35752705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
